Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Stud

Authors

Tristan Barber (ORCID: https://orcid.org/0000-0003-1914-4891)
Yuk Lam Wong (ORCID: https://orcid.org/0000-0003-3085-7235)
Chloe Orkin (ORCID: https://orcid.org/0000-0001-6168-6745)
Ruth Byrne
Emily Clarke (ORCID: https://orcid.org/0000-0001-9340-1417)
Julie Fox (ORCID: https://orcid.org/0000-0002-0583-8019)
Bakita Kasadha (ORCID: https://orcid.org/0000-0003-2862-183X)
Amanda Clarke (ORCID: https://orcid.org/0000-0002-4632-2035)
Joanne Haviland (ORCID: https://orcid.org/0000-0001-5728-3636)
Vanessa Apea (ORCID: https://orcid.org/0000-0002-0533-8292)
Sara Paparini (ORCID: https://orcid.org/0000-0002-1909-2481)
Kyle Ring (ORCID: https://orcid.org/0000-0003-4016-4643)
Rosalie Hayes (ORCID: https://orcid.org/0000-0003-4046-4101)

Institutions

University of Liverpool (GB)
King's College - North Carolina (US)
Queen Mary University of London (GB)
Royal Free London NHS Foundation Trust (GB)
King's College London (GB)
Guy's and St Thomas' NHS Foundation Trust (GB)
Barts Health NHS Trust (GB)
Aintree University Hospitals NHS Foundation Trust (GB)
Chelsea and Westminster Hospital NHS Foundation Trust (GB)
University of Oxford (GB)
University Hospitals Sussex NHS Foundation Trust (GB)
University College London (GB)

Publication Details

Journal: Clinical Infectious Diseases
Published: 2024-10-28
DOI: https://doi.org/10.1093/cid/ciae523
Citations: 10
Primary Topic: HIV/AIDS Research and Interventions
Type: article
Field-Weighted Citation Impact: 3.89

Funders

Pfizer
AstraZeneca
Gilead Sciences
Queen Mary University of London
ViiV Healthcare
Bavarian Nordic
Janssen Pharmaceuticals

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Stud

Tristan Barber, Yuk Lam Wong, Chloe Orkin, Ruth Byrne et al.

Oct 28, 2024

10 citations

Clinical Infectious Diseases

HIV/AIDS Research and Interventions

3.89

article

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Stud

Tristan Barber, Yuk Lam Wong, Chloe Orkin, Ruth Byrne, Emily Clarke, Julie Fox, Bakita Kasadha, Amanda Clarke, Joanne Haviland, Vanessa Apea, Sara Paparini, Kyle Ring, Rosalie Hayes

October 28, 2024article en

10 citations

Abstract

No abstract available for this paper.

Clinical Infectious DiseasesVol. 80(5)

University of Liverpool (GB), King's College - North Carolina (US), Queen Mary University of London (GB), Royal Free London NHS Foundation Trust (GB), King's College London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Barts Health NHS Trust (GB), Aintree University Hospitals NHS Foundation Trust (GB), Chelsea and Westminster Hospital NHS Foundation Trust (GB), University of Oxford (GB), University Hospitals Sussex NHS Foundation Trust (GB), University College London (GB)

Pfizer, AstraZeneca, Gilead Sciences, Queen Mary University of London, ViiV Healthcare, Bavarian Nordic, Janssen Pharmaceuticals

Gender equality

Openalex Percentile: Top 6%

HIV/AIDS Research and Interventions

3.89

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.